WiSE-UP Post-Approval Study
Heart Failure (Cardiac Resynchronization Therapy)
Post-MarketActive
Key Facts
Indication
Heart Failure (Cardiac Resynchronization Therapy)
Phase
Post-Market
Status
Active
Company
About EBR Systems
EBR Systems is a pioneering private medical device company commercializing a novel, leadless solution for cardiac resynchronization therapy (CRT). Its flagship WiSE System uses ultrasound energy to power a miniaturized electrode implanted in the left ventricle, offering a physiological pacing approach for patients who cannot be treated effectively with traditional lead-based systems. The company has achieved regulatory approvals (CE Mark and FDA PMA) and is in the commercial stage, supported by recent Medicare reimbursement decisions. EBR's technology addresses a significant unmet need in the large and growing heart failure market, positioning it as a potential leader in next-generation CRT.
View full company profile